
    
      -  This research study is a Phase II clinical trial. Phase II clinical trials test the
           safety and effectiveness of an investigational intervention to learn whether the
           intervention works in treating a specific disease. "Investigational" means that the
           intervention is being studied.

        -  This is a study designed to evaluate the efficacy and safety of palbociclib in recurrent
           brain metastases. Palbociclib is being studied for use in the treatment of a broad range
           of cancers. This type of drug inhibits cell growth in the cells called cyclin-dependent
           kinases which promote tumor cell proliferation.

        -  The FDA (the U.S. Food and Drug Administration) has not approved palbociclib for
           participants specific disease but it has been approved for other uses
    
  